logo
logo

Lantheus Holdings Appoints Dr Jeffrey Humphrey As Chief Medical Officer and Dr Jean Claude Provost As Chief Science Officer

May 16, 2024about 1 year ago

Position

Chief Science Officer

Company

Lantheus Holdings

Jean -Claude Provost
BedfordTherapeuticsBiotechnologyHealth Care

Description

Lantheus Holdings has appointed Dr Jeffrey Humphrey as chief medical officer (CMO) and Dr Jean-Claude Provost as chief science officer (CSO), effective May 28, 2024.

Company Information

Company

Lantheus Holdings

Location

Bedford, Massachusetts, United States

About

Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com.

Related People

Sign in to view contact details

Sign in to view contact details

Sign in to view contact details

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months